"Thumbs up!"
Randomised double blind clinical control trial comparin injections of botulinum toxin A with saline placebo to the intrinsic muscles of the thumb in children with cerebral palsy to assess improved performance in individual goal areas as measured by goal attainment scaling.
Dr Lisa Copeland
40 participants
Nov 6, 2006
Interventional
Conditions
Summary
To examine whether botulinum toxin – A (BTX-A) injections into the intrinsic muscles of the thumb, when combined with a regimen of occupational therapy and home therapy improves the attainment of individual goals when compared to a home and occupational therapy program alone.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Treatment group: Single episode of Botulinum toxin A (BTX-A) injections into the intrinsic muscles of the thumb (dosage of 0.5 U/kg BTX-A (max 20 units) injected into flexor pollicis brevis, opponens pollicis or adductor pollicis to a maximum total dose of 1.5 U/kg or 30 units) + casting for one week, home therapy program (to be carried out daily for 8 weeks) and resting hand splints to be worn daily (for resting time over night eg 10 hours) for 8 weeks. Botulinum toxin A dosing to be determined by blinded physician. Muscles injected dependent upon clinical determinants of spasticity in those muscles Home therapy programme will involve a range of activities selected according to the child's individual goals and will take approximately 20 minutes per day. For example: strengthening excercises for thumb flexors with playdoh.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000492550